Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.8B | 4.7B | 4.5B | 4.1B |
Cost of revenue | 3.0B | 3B | 2.9B | 2.6B |
Gross profit | 1.8B | 1.7B | 1.6B | 1.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 806M | 365M | 672M | 705M |
Operating income | 320M | 269M | 350M | 280M |
Non operating interest income | ||||
Income | 6M | 8M | 262M | 141M |
Expense | 59M | 76M | 342M | 172M |
Other income expense | — | — | — | — |
Pretax income | 212M | 166M | 276M | 274M |
Tax provision | 57M | 52M | 52M | 54M |
Net income | 155M | 114M | 224M | 220M |
Basic EPS | 0.5 | — | 0.8 | 0.8 |
Diluted EPS | 0.5 | — | 0.8 | 0.8 |
Basic average shares | 286.4M | — | 289.3M | 280.3M |
Diluted average shares | 286.9M | — | 289.3M | 280.3M |
EBITDA | 471M | 458M | 751M | 534M |
Net income from continuing op. | 212M | 166M | 276M | 274M |
Minority interests | -5M | -4M | -7M | -3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |